Related Experiment Videos
[NK activities in cancer patients--their modification by an immunopotentiator]
Abstract:
NK activity of patients with cancer against gastric carcinoma cell line KATO-III, lung carcinoma cell line A-549 as well as K-562 was significantly lower than that in the control group. We investigated in vitro effects of immunopotentiator, OK-432, on the effector cells of both healthy donors and cancer patients. NK activity of healthy donors was clearly augmented after treatment of effector cells with OK-432. NK activity of some patients with cancer, however, showed no augmentation after OK-432 treatment. These results might be helpful for monitoring cancer patients from immunological view point.
Insights
Natural killer (NK) cell activity is lower in cancer patients. The immunopotentiator OK-432 boosts NK activity in healthy donors but not all cancer patients, suggesting potential for immune monitoring.
Area of Science:
- Immunology
- Cancer Research
- Cell Biology
Context:
- Natural killer (NK) cell activity is crucial for immune surveillance against cancer.
- Patients with gastric and lung carcinoma exhibit significantly reduced NK activity compared to healthy individuals.
- Assessing NK cell function is vital for understanding cancer immune evasion.
Purpose:
- To investigate the in vitro effects of the immunopotentiator OK-432 on NK cell activity in cancer patients and healthy donors.
- To determine if OK-432 can augment NK cell activity in individuals with compromised immune function due to cancer.
- To explore the potential of NK cell activity modulation as an immunological monitoring tool for cancer patients.
Summary:
- NK cell activity against gastric carcinoma (KATO-III), lung carcinoma (A-549), and K-562 cell lines was significantly lower in cancer patients than in the control group.
- Treatment with the immunopotentiator OK-432 augmented NK activity in effector cells from healthy donors.
- However, NK activity in some cancer patients did not show augmentation after OK-432 treatment, indicating varied responses.
Impact:
- These findings suggest that NK cell activity and its response to immunopotentiators like OK-432 could serve as a valuable immunological marker for monitoring cancer patients.
- Understanding these immune dynamics may aid in developing personalized immunotherapeutic strategies.
- Further research into the mechanisms behind non-responsive patients could reveal new therapeutic targets.